Venture capital firms are crucial for biotech startups, providing financial and operational support. Notables in the industry include Third Rock Ventures, Sofinnova and OrbiMed, among others. Over time, many pharma and biotech companies have also started their own venture capital funds to identify and invest in potential acquisitions. This article explores the work of 10 significant pharma and biotech venture capital arms, including AbbVie Ventures, Astellas Venture Management, JJDC, Leaps by Bayer, M Ventures, Novartis Venture Fund, Novo Holdings, Pfizer Ventures, Regeneron Ventures, and Sanofi Ventures.
Paul Markovich’s 4 Ideas to Reduce Healthcare Costs
Paul Markovich, president and CEO of Ascendiun, shared his ideas for bringing down healthcare costs, including digital health records and changing how healthcare is paid
